LRP6 and neoplasm: Similarly, a recent study reported single‐domain antibody fragments binding to LRP6 strongly inhibited the growth of Wnt‐hypersensitive intestinal stem cells through stem cell exhaustion and promoting terminal differentiation provides a promising strategy for treating Wnt‐hypersensitive tumours.57